Variant report
Variant | esv275236 |
---|---|
Chromosome Location | chr21:41110282-41119411 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:124)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr21:41110633-41110673 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr21:41110820-41110858 | Lung_OC | lung: | n/a | n/a |
3 | CTCF | chr21:41113561-41113650 | LNCaP | prostate: | n/a | n/a |
4 | CTCF | chr21:41116780-41116845 | GM13976 | blood: | n/a | n/a |
5 | FOSL2 | chr21:41114625-41114825 | MCF-7 | breast: | n/a | n/a |
6 | FOXA1 | chr21:41114589-41114847 | T-47D | breast: | n/a | n/a |
7 | FOXA1 | chr21:41114607-41114812 | T-47D | breast: | n/a | n/a |
8 | GATA3 | chr21:41114614-41114815 | MCF-7 | breast: | n/a | n/a |
9 | GATA3 | chr21:41114544-41114809 | MCF-7 | breast: | n/a | n/a |
10 | GATA3 | chr21:41114571-41115025 | MCF-7 | breast: | n/a | n/a |
11 | GATA3 | chr21:41114572-41114891 | T-47D | breast: | n/a | n/a |
12 | HA-E2F1 | chr21:41114175-41114771 | MCF-7 | breast: | n/a | n/a |
13 | MAFF | chr21:41111360-41111415 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr21:41111341-41111418 | HepG2 | liver: | n/a | n/a |
15 | MAFK | chr21:41111336-41111452 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr21:41118707-41118812 | HepG2 | liver: | n/a | n/a |
17 | MAFK | chr21:41111333-41111432 | IMR90 | lung: | n/a | n/a |
18 | SIN3AK20 | chr21:41109208-41110327 | MCF-7 | breast: | n/a | n/a |
19 | TCF7L2 | chr21:41114532-41115040 | MCF-7 | breast: | n/a | chr21:41114819-41114833 |
20 | YY1 | chr21:41117784-41117918 | K562 | blood: | n/a | n/a |
21 | ZNF217 | chr21:41114538-41114938 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:41117225-41117275 | HL-60 | blood: | n/a |
2 | chr21:41116522-41116572 | BE2_C | brain: | n/a |
3 | chr21:41117225-41117275 | HL-60 | blood: | n/a |
4 | chr21:41116522-41116572 | BE2_C | brain: | n/a |
5 | chr21:41116522-41116572 | PrEC | prostate: | n/a |
6 | chr21:41117225-41117275 | SAEC | small airway: | n/a |
7 | chr21:41117225-41117275 | PFSK-1 | brain: | n/a |
8 | chr21:41116522-41116572 | AG04449 | skin: | fetal |
9 | chr21:41116522-41116572 | T-47D | breast: | n/a |
10 | chr21:41116522-41116572 | HEK293 | kidney: | embryo |
11 | chr21:41116522-41116572 | MCF10A-Er-Src | breast: | n/a |
12 | chr21:41116522-41116572 | GM19239 | blood: | n/a |
13 | chr21:41117225-41117275 | MCF10A-Er-Src | breast: | n/a |
14 | chr21:41117225-41117275 | HRPEpiC | eye: | n/a |
15 | chr21:41117225-41117275 | LNCaP | prostate: | n/a |
16 | chr21:41117225-41117275 | HPAEpiC | pulmonary alveolar: | n/a |
17 | chr21:41117225-41117275 | HEEpiC | esophagus: | n/a |
18 | chr21:41117225-41117275 | MCF-7 | breast: | n/a |
19 | chr21:41117225-41117275 | ECC-1 | luminal epithelium: | n/a |
20 | chr21:41116522-41116572 | HNPCEpiC | eye: | n/a |
21 | chr21:41117225-41117275 | HCT-116 | colon: | n/a |
22 | chr21:41117225-41117275 | GM12878 | blood: | n/a |
23 | chr21:41116522-41116572 | NB4 | blood: | n/a |
24 | chr21:41116522-41116572 | NHBE | bronchial: | n/a |
25 | chr21:41117225-41117275 | HepG2 | liver: | n/a |
26 | chr21:41116522-41116572 | IMR90 | lung: | fetal |
27 | chr21:41117225-41117275 | U87 | brain: | n/a |
28 | chr21:41116522-41116572 | K562 | blood: | n/a |
29 | chr21:41116522-41116572 | HRCEpiC | kidney: | n/a |
30 | chr21:41117225-41117275 | HMEC | breast: | n/a |
31 | chr21:41117225-41117275 | AG09319 | gingival: | n/a |
32 | chr21:41116522-41116572 | MCF-7 | breast: | n/a |
33 | chr21:41116522-41116572 | ovcar-3 | ovarian: | n/a |
34 | chr21:41116522-41116572 | HL-60 | blood: | n/a |
35 | chr21:41117225-41117275 | Caco-2 | colon: | n/a |
36 | chr21:41116522-41116572 | SK-N-SH | brain: | n/a |
37 | chr21:41116522-41116572 | NT2-D1 | testis: | n/a |
38 | chr21:41117225-41117275 | PANC-1 | pancreas: | n/a |
39 | chr21:41117225-41117275 | SKMC | muscle: | n/a |
40 | chr21:41117225-41117275 | H1-hESC | embryonic stem cell: | embryo |
41 | chr21:41117225-41117275 | GM19239 | blood: | n/a |
42 | chr21:41116522-41116572 | HPAEpiC | pulmonary alveolar: | n/a |
43 | chr21:41116522-41116572 | SK-N-SH_RA | brain: | n/a |
44 | chr21:41117225-41117275 | NHBE | bronchial: | n/a |
45 | chr21:41117225-41117275 | HNPCEpiC | eye: | n/a |
46 | chr21:41117225-41117275 | CMK | blood: | n/a |
47 | chr21:41116522-41116572 | LNCaP | prostate: | n/a |
48 | chr21:41117225-41117275 | GM12892 | blood: | n/a |
49 | chr21:41116522-41116572 | RPTEC | kidney: | n/a |
50 | chr21:41117225-41117275 | GM12891 | blood: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:41085205..41088011-chr21:41112686..41115638,2 | MCF-7 | breast: | |
2 | chr21:41108059..41110631-chr21:41112030..41114431,2 | MCF-7 | breast: | |
3 | chr21:40888055..40890382-chr21:41107871..41110600,2 | MCF-7 | breast: | |
4 | chr21:41118789..41121502-chr21:41136765..41138744,2 | MCF-7 | breast: | |
5 | chr21:41108059..41110631-chr21:41112030..41114431,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
IGSF5 | TF binding region |
IGSF5 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4816642 | chr21:41110282-41110283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574497838 | chr21:41110284-41110285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543206821 | chr21:41110288-41110289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563508436 | chr21:41110315-41110316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374481485 | chr21:41110368-41110369 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542613395 | chr21:41110398-41110399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs391212 | chr21:41110406-41110407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146710529 | chr21:41110454-41110455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545737856 | chr21:41110459-41110460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73904409 | chr21:41110486-41110487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377469387 | chr21:41110495-41110496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527714219 | chr21:41110527-41110528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201882474 | chr21:41110554-41110555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560511047 | chr21:41110572-41110573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528412440 | chr21:41110573-41110574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185852121 | chr21:41110586-41110587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530213516 | chr21:41110615-41110616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140344489 | chr21:41110625-41110626 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145314594 | chr21:41110627-41110628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117234594 | chr21:41110633-41110634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs137949551 | chr21:41110645-41110646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117564627 | chr21:41110656-41110657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190965719 | chr21:41110697-41110698 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183099504 | chr21:41110728-41110729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535635290 | chr21:41110736-41110737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537189132 | chr21:41110752-41110753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs367714191 | chr21:41110758-41110759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371447762 | chr21:41110762-41110763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552713682 | chr21:41110763-41110764 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552814054 | chr21:41110772-41110773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548546695 | chr21:41110819-41110820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527546641 | chr21:41110820-41110821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76057996 | chr21:41110827-41110828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572822373 | chr21:41110909-41110910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs416642 | chr21:41110940-41110941 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs185887367 | chr21:41110966-41110967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530135752 | chr21:41110972-41110973 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543924740 | chr21:41110973-41110974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563714960 | chr21:41110974-41110975 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532718925 | chr21:41110997-41110998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190688494 | chr21:41111008-41111009 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183401843 | chr21:41111009-41111010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528806266 | chr21:41111013-41111014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547869528 | chr21:41111014-41111015 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555300520 | chr21:41111017-41111018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374906604 | chr21:41111018-41111019 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188402542 | chr21:41111029-41111030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs460528 | chr21:41111072-41111073 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs370639370 | chr21:41111076-41111077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs60218783 | chr21:41111094-41111095 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Down syndrome | 20877625 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21147910 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 22522925 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:41104200-41138400 | Weak transcription | Pancreas | Pancrea |
2 | chr21:41107800-41119400 | Enhancers | Placenta | Placenta |
3 | chr21:41108000-41111600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr21:41108600-41110800 | Enhancers | Placenta Amnion | Placenta Amnion |
5 | chr21:41110000-41148400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr21:41110800-41113800 | Weak transcription | Placenta Amnion | Placenta Amnion |
7 | chr21:41111600-41113800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr21:41113800-41115600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr21:41113800-41116000 | Enhancers | Placenta Amnion | Placenta Amnion |
10 | chr21:41114200-41114400 | Enhancers | Esophagus | oesophagus |
11 | chr21:41114600-41117000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr21:41115000-41115200 | Enhancers | Esophagus | oesophagus |
13 | chr21:41115600-41122000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr21:41117000-41117200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr21:41117000-41117200 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
16 | chr21:41119400-41119800 | Weak transcription | Placenta | Placenta |